Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis.

Johnsen E, Fathian F, Kroken RA, Steen VM, Jørgensen HA, Gjestad R, Løberg EM.

BMC Psychiatry. 2016 Mar 14;16:60. doi: 10.1186/s12888-016-0769-x.

2.

Effect of apolipoprotein E (APO E) polymorphism on leptin in Alzheimer's disease.

Agarwal R, Talwar P, Kushwaha SS, Tripathi CB, Kukreti R.

Ann Indian Acad Neurol. 2015 Jul-Sep;18(3):320-6. doi: 10.4103/0972-2327.157255.

3.

Trajectories of peripheral interleukin-6, structure of the hippocampus, and cognitive impairment over 14 years in older adults.

Metti AL, Aizenstein H, Yaffe K, Boudreau RM, Newman A, Launer L, Gianaros PJ, Lopez OL, Saxton J, Ives DG, Kritchevsky S, Vallejo AN, Rosano C.

Neurobiol Aging. 2015 Nov;36(11):3038-44. doi: 10.1016/j.neurobiolaging.2015.07.025. Epub 2015 Jul 28.

PMID:
26279115
4.

Longitudinal associations between physical and cognitive performance among community-dwelling older adults.

Tolea MI, Morris JC, Galvin JE.

PLoS One. 2015 Apr 13;10(4):e0122878. doi: 10.1371/journal.pone.0122878. eCollection 2015.

5.

Patients with type 2 diabetes exhibit cognitive impairment with changes of metabolite concentration in the left hippocampus.

Wang Y, Xu XY, Feng CH, Li YL, Ge X, Zong GL, Wang YB, Feng B, Zhang P.

Metab Brain Dis. 2015 Aug;30(4):1027-34. doi: 10.1007/s11011-015-9670-4. Epub 2015 Apr 16.

6.

Primary prevention of Alzheimer's disease: is it an attainable goal?

Han JY, Han SH.

J Korean Med Sci. 2014 Jul;29(7):886-92. doi: 10.3346/jkms.2014.29.7.886. Epub 2014 Jul 11. Review.

7.

Trajectories of inflammatory markers and cognitive decline over 10 years.

Metti AL, Yaffe K, Boudreau RM, Simonsick EM, Carnahan RM, Satterfield S, Harris TB, Ayonayon HN, Rosano C, Cauley JA; Health ABC Study.

Neurobiol Aging. 2014 Dec;35(12):2785-90. doi: 10.1016/j.neurobiolaging.2014.05.030. Epub 2014 Jun 6.

8.
9.

Effects of exercise program on physiological functions in postmenopausal women with metabolic syndrome.

Heli V, Ihab H, Kun H, Brad M, Jessica W, Vera N.

Int J Gerontol. 2013 Dec;7(4):231-235.

10.

Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers.

Reitz C, Mayeux R.

Biochem Pharmacol. 2014 Apr 15;88(4):640-51. doi: 10.1016/j.bcp.2013.12.024. Epub 2014 Jan 4. Review.

11.

Executive functioning and the metabolic syndrome: a project FRONTIER study.

Falkowski J, Atchison T, Debutte-Smith M, Weiner MF, O'Bryant S.

Arch Clin Neuropsychol. 2014 Feb;29(1):47-53. doi: 10.1093/arclin/act078. Epub 2013 Oct 22.

12.

The emerging role of dietary fructose in obesity and cognitive decline.

Lakhan SE, Kirchgessner A.

Nutr J. 2013 Aug 8;12:114. doi: 10.1186/1475-2891-12-114. Review.

13.

Low cerebral blood flow is associated with lower memory function in metabolic syndrome.

Birdsill AC, Carlsson CM, Willette AA, Okonkwo OC, Johnson SC, Xu G, Oh JM, Gallagher CL, Koscik RL, Jonaitis EM, Hermann BP, LaRue A, Rowley HA, Asthana S, Sager MA, Bendlin BB.

Obesity (Silver Spring). 2013 Jul;21(7):1313-20. doi: 10.1002/oby.20170. Epub 2013 May 19.

14.

Risk factors for mild cognitive impairment among Mexican Americans.

O'Bryant SE, Johnson L, Reisch J, Edwards M, Hall J, Barber R, Devous MD Sr, Royall D, Singh M.

Alzheimers Dement. 2013 Nov;9(6):622-631.e1. doi: 10.1016/j.jalz.2012.12.007. Epub 2013 May 2.

16.

Does mild cognitive impairment affect the occurrence of radiographic knee osteoarthritis? A 3-year follow-up in the ROAD study.

Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Tanaka S, Akune T.

BMJ Open. 2012 Nov 19;2(6). pii: e001520. doi: 10.1136/bmjopen-2012-001520. Print 2012.

17.

The impact of inflammation on cognitive function in older adults: implications for healthcare practice and research.

Sartori AC, Vance DE, Slater LZ, Crowe M.

J Neurosci Nurs. 2012 Aug;44(4):206-17. doi: 10.1097/JNN.0b013e3182527690. Review.

18.

TCF7L2 polymorphism and cognitive test performance in cardiovascular disease.

Keary TA, Gunstad J, Benitez A, Spitznagel MB, McCaffery J, McGeary JE, Poppas A, Paul RH, Sweet LH, Cohen RA.

Psychogeriatrics. 2012 Jun;12(2):93-8. doi: 10.1111/j.1479-8301.2011.00398.x.

19.

Metabolic syndrome and localization of white matter hyperintensities in the elderly population.

Portet F, Brickman AM, Stern Y, Scarmeas N, Muraskin J, Provenzano FA, Berr C, Bonafé A, Artero S, Ritchie K, Akbaraly TN.

Alzheimers Dement. 2012 Oct;8(5 Suppl):S88-95.e1. doi: 10.1016/j.jalz.2011.11.007. Epub 2012 Jun 6.

20.

Session III: Mechanisms of age-related cognitive change and targets for intervention: inflammatory, oxidative, and metabolic processes.

Craft S, Foster TC, Landfield PW, Maier SF, Resnick SM, Yaffe K.

J Gerontol A Biol Sci Med Sci. 2012 Jun;67(7):754-9. doi: 10.1093/gerona/gls112. Epub 2012 May 8.

Items per page

Supplemental Content

Write to the Help Desk